PSYC’s Psychedelic Spotlight Surpasses 1M Page View Milestone
PSYC Corporation (OTCPink: PSYC) has surpassed a significant milestone with over 1.1 million page views on its Psychedelic Spotlight platform for May 2022. This achievement includes nearly 100,000 organic visits and 1.2 million total impressions. CEO David Flores emphasized the importance of building an authentic audience, while Marketing Director Maria Holyanova noted the growing public interest in psychedelics. The company aims to maintain this momentum as it expands into the psychedelic lifestyle sector and seeks to optimize monetization strategies.
- Surpassed 1.1 million page views in May 2022, marking a significant milestone for the company.
- Achieved nearly 100,000 organic visits, indicating strong audience engagement.
- Continues to rank highly under the category of 'psychedelic news' on Google, establishing itself as a leader in the sector.
- Plans to expand into the psychedelic lifestyle space, aiming to attract diverse audiences.
- Growing audience engagement opens avenues for optimizing monetization and long-term revenue growth.
- None.
LAS VEGAS, NV, June 13, 2022 (GLOBE NEWSWIRE) -- PSYC Corporation (OTCPink: PSYC) (“PSYC” or the “Company”) a media leader for the emerging sector of medicinal psychedelics and authorities behind Psychedelic Spotlight, a top ranking psychedelic news and information platform, is pleased to announce that in tallying more than 1.1M page views in the month of May, the Company’s Psychedelic Spotlight media platform not only hit, but successfully surpassed what has been a long-standing goal and milestone for the Company since the platform was launched in July of 2020.
Per the Company, other notable statistics achieved within the month of May, as reported through Google Analytics, were just under 1.2M total impressions, nearly 100,000 organic visits to the site, and a record 5.9 pages per visit, which, combined with its ongoing top ranking on Google under the search category “psychedelic news”, continues to reinforce Psychedelic Spotlight’s emergence as a recognized and respected leader for news, information, and unique perspective within the psychedelics sector.
“Eclipsing the 1M page view marker is something that we’ve had our sights set on for quite some time,” said PSYC CEO, David Flores. “We could have arrived here sooner had we taken some of the short cuts we believe some of our competitors took over the past couple of years. However, it’s been critical for us to build Psychedelic Spotlight as organically as possible, given the value we recognize in establishing a true and loyal audience made up of actual human beings and not bots. This audience is a factor that we expect to play a key role in some of the other ventures we are preparing for PSYC, so the value and importance of its authenticity cannot be understated.”
Flores concluded his statement with: “I also have to tip my hat to the amazing group of individuals that we have working for Psychedelic Spotlight. Without the inspiring level of passion, dedication and creativity they each bring to the workplace on a daily basis, Psychedelic Spotlight would not be anywhere close to the multimedia leader it’s become for the growing psychedelic space.”
“The impressive growth of our audience is an undeniable result of the drive, commitment and uniqueness that our team brings tirelessly to work each day. Without their respective skill sets, we wouldn’t have compelling stories or articles that resonate with the public”, said Psychedelic Spotlight Marketing Director, Maria Holyanova. “1M page views is also a great indicator that public interest in the psychedelic space is a growing trend and not just a fad. More and more people are seeking information on the potential healing benefits of psychedelics and are discovering this community thanks to Psychedelic Spotlight.”
Psychedelic Spotlight Executive Director, Swati Sharma, touted the platform’s success, adding, “We are incredibly proud of the Psychedelic Spotlight team achieving this milestone of garnering 1M page views for the website this month. Our content team worked tirelessly to nail the perfect combination of both strategy and volume of content to the website, and this inevitably resulted in our dynamic growth over the past two quarters. As we continue to expand into the psychedelic lifestyle space, we expect to attract even more diverse audiences to the platform, and this will assist us in bringing psychedelics to the mainstream in a responsible, current, and engaging way.”
PSYC CFO Craig Schlesinger concluded with, “The analytical trends are undeniable. Not only is Psychedelic Spotlight’s audience growing rapidly, they’re also engaging on the platform for longer, thus consuming more content. Establishing this integral brand loyalty and goodwill with our audience creates opportunities to optimize monetization as well as provide scale for long term revenue growth. It’s an exciting time for Team PSYC.”
The following graphs are intended to provide a visual illustration of the month-over-month growth of Psychedelic Spotlight in page views and impressions. All data and information has been sourced directly from Google Analytics.
About PSYC Corporation (OTCPink: PSYC)
At PSYC Corporation we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.
PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, we believe investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.
We are dedicated to a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19 and the success of the current vaccine distribution, the adverse effect of the Omicron variant, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website and is not incorporated by reference into such reports.
Disclaimer: PSYC Corporation does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.
Corporate Contact:
PSYC Corporation (PSYC)
www.psyccorporation.com
(702) 761-6716
info@psyccorporation.com
OTCPINK: PSYC
Attachment
FAQ
What milestone did PSYC Corporation achieve in May 2022?
How many organic visits did Psychedelic Spotlight receive in May 2022?
What does the growth of PSYC's audience indicate?
What future plans does PSYC Corporation have for its platform?
How does PSYC Corporation rank in its industry as of May 2022?
